News
New weight loss pill could benefit people with Type 2 diabetes: Drugmaker
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce hemoglobin A1C levels on average by 1.3-1.6% and also help people lose up to 16 pounds, or about 7.9% of their body weight.
News-Medical.Net on MSN1d
New findings highlight a shifting landscape for weight loss and glucose managing medicationsWhen it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.
A U.S. senator said a GLP-1 drug changed his life — and now he's calling for widespread access to anti-obesity medications. In a New York Times ... approved for weight loss, chronic weight ...
As revenues fall in diabetes treatments, has the industry found a new revenue driver in weight-loss treatments ... as it progresses its drug candidate for obesity into mid-stage trials.
Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...
Amy Schumer’s experience with Mounjaro has been vastly different from when she tried an alternative weight-loss medication years ago. Schumer, 43, praised the effects of Mounjaro (also known as ...
Novo Nordisk to Pay $2 Billion for New Weight Loss Drug TUESDAY, March 25, 2025 (HealthDay News) -- Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 ...
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback